Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon

Shaikh Emaran Shaikh Ismail Teli; Jaiprakash Ramanand; Chetan Suresh Bhangale; Harshal Murlidhar Mahajan; Rajshree Mandhare

doi:10.5455/njppp.2022.12.07266202106082021

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 20 Aug 2021

Natl J Physiol Pharm Pharmacol. 2022; 12(1): 65-68

doi: 10.5455/njppp.2022.12.07266202106082021

Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon

Shaikh Emaran Shaikh Ismail Teli, Jaiprakash Ramanand, Chetan Suresh Bhangale, Harshal Murlidhar Mahajan, Rajshree Mandhare.

Cited By:2

Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (COVID 19) is a global pandemic since December 2019. The subject expert committee of the Central Drugs Standard Control Organization made recommendations for Restricted Emergency Approval of COVID-19 virus vaccine of M/s Serum Institute of India ChAdOx1 nCoV-19 vaccine (AZD1222) COVISHIELD which was developed at Oxford University. In India, this vaccine was launched on January 16, 2021, and healthcare workers were included first in this vaccination program.

Aim and Objectives: This study aimed to record and analyzes all the adverse events following the immunization (AEFI) in healthcare workers for monitoring the safety and find the correlation if any.

Materials and Methods: This was a prospective observational study. After obtaining Institutional Ethics committee approval, we collected the data by phone call to the participants within 3 days after the first and second dose of the vaccine. We collected the data from 100 healthcare workers randomly with their consent.

Results: The most common adverse effect found was myalgia followed by local pain at the injection site after the first dose. About 92% of participants did not react to the second dose of the vaccine.

Conclusion: There were no serious adverse events after the first as well as the second dose of vaccination. More studies and monitoring are needed to find out any unexpected reactions following COVID-19 vaccination.

Key words: Adverse Events following the Immunization; Coronavirus 19; CovishieldTM; Healthcare Workers; Immunity; Vaccine

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Shaikh Emaran Shaikh Ismail Teli Articles by Jaiprakash Ramanand Articles by Chetan Suresh Bhangale Articles by Harshal Murlidhar Mahajan Articles by Rajshree Mandhare
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Teli SESI, Ramanand J, Bhangale CS, Mahajan HM, Mandhare R. Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon. Natl J Physiol Pharm Pharmacol. 2022; 12(1): 65-68.

doi:10.5455/njppp.2022.12.07266202106082021

Web Style

Teli SESI, Ramanand J, Bhangale CS, Mahajan HM, Mandhare R. Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon. https://www.njppp.com/?mno=103401 [Access: June 27, 2026].

doi:10.5455/njppp.2022.12.07266202106082021

AMA (American Medical Association) Style

Teli SESI, Ramanand J, Bhangale CS, Mahajan HM, Mandhare R. Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon. Natl J Physiol Pharm Pharmacol. 2022; 12(1): 65-68.

doi:10.5455/njppp.2022.12.07266202106082021

Vancouver/ICMJE Style

Teli SESI, Ramanand J, Bhangale CS, Mahajan HM, Mandhare R. Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon. Natl J Physiol Pharm Pharmacol. (2022), [cited June 27, 2026]; 12(1): 65-68.

doi:10.5455/njppp.2022.12.07266202106082021

Harvard Style

Teli, S. E. S. I., Ramanand, . J., Bhangale, . C. S., Mahajan, . H. M. & Mandhare, . R. (2022) Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon. Natl J Physiol Pharm Pharmacol, 12 (1), 65-68.

doi:10.5455/njppp.2022.12.07266202106082021

Turabian Style

Teli, Shaikh Emaran Shaikh Ismail, Jaiprakash Ramanand, Chetan Suresh Bhangale, Harshal Murlidhar Mahajan, and Rajshree Mandhare. 2022. Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon. National Journal of Physiology, Pharmacy and Pharmacology, 12 (1), 65-68.

doi:10.5455/njppp.2022.12.07266202106082021

Chicago Style

Teli, Shaikh Emaran Shaikh Ismail, Jaiprakash Ramanand, Chetan Suresh Bhangale, Harshal Murlidhar Mahajan, and Rajshree Mandhare. "Analysis of all the adverse events following immunization by CovishieldTM vaccine among healthcare workers at Government Medical College, Jalgaon." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 65-68.

doi:10.5455/njppp.2022.12.07266202106082021

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2022.12.07266202106082021

APA (American Psychological Association) Style

doi:10.5455/njppp.2022.12.07266202106082021

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article